Anixa Biosciences (Anixa Biosciences) EV-to-EBITDA : -6.48 (As of Apr. 25, 2024)

Anixa Biosciences EV-to-EBITDA Chart

Anixa Biosciences Annual Data
	Trend	Oct14	Oct15	Oct16	Oct17	Oct18	Oct19	Oct20	Oct21	Oct22	Oct23
EV-to-EBITDA		Get a 7-Day Free Trial					-6.58	-4.09	-8.20	-10.32	-6.73

Anixa Biosciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EV-to-EBITDA	Get a 7-Day Free Trial															-8.54	-8.59	-7.38	-6.73	-9.95

Competitive Comparison of Anixa Biosciences's EV-to-EBITDA

For the Biotechnology subindustry, Anixa Biosciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anixa Biosciences's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anixa Biosciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Anixa Biosciences's EV-to-EBITDA falls into.

Anixa Biosciences EV-to-EBITDA Calculation

Anixa Biosciences's EV-to-EBITDA for today is calculated as:

Anixa Biosciences's current Enterprise Value is $77.81 Mil.
Anixa Biosciences's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anixa Biosciences  (NAS:ANIX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Anixa Biosciences's PE Ratio for today is calculated as:

Anixa Biosciences's share price for today is $2.98.
Anixa Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.340.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Anixa Biosciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Anixa Biosciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Anixa Biosciences (Anixa Biosciences) Business Description